Investors

News Releases

Date Title  
Toggle Summary Aralez Reports First Quarter 2017 Financial Results
-First Quarter 2017 Net Revenues of $26.0 Million - -Cost Savings Plan Expected to Reduce 2017 Expenses by $23.0 Million ; Improved 2017 Adjusted EBITDA Guidance- -Currently Implementing a Bold Program Aimed at Allowing All Patients to Access Yosprala for Only $10.00 Per Month- MISSISSAUGA, Ontario
Toggle Summary Aralez Announces Voting Results From 2017 Annual And Special Meeting Of Shareholders
MISSISSAUGA, Ontario , May 3, 2017 /PRNewswire/ --   Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company") today announced the results of the matters voted upon at the Company's 2017 annual and special meeting (the "Meeting") of the shareholders of the Company (the
Toggle Summary Aralez To Report First Quarter 2017 Financial Results On May 9, 2017
-Executive Management to Host Conference Call on May 9, 2017 at 9:00 a.m. ET - MISSISSAUGA, Ontario , April 25, 2017 /PRNewswire/ --  Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) today announced that it will report its first quarter 2017 financial results on Tuesday, May 9, 2017 , before
Toggle Summary Aralez Announces Reduction In U.S. Sales Force And Cost Savings Program
-32% Reduction in the U.S. Sales Force- -Strategic Realignment of Resources with an Emphasis on the Zontivity® Launch- -Support Yosprala® with Direct Selling Efforts Only- -Company Commences Spend Reductions Across Business- MISSISSAUGA, Ontario , April 5, 2017 /PRNewswire/ --   Aralez
Toggle Summary Aralez CEO Purchases 500,000 Shares Of Company Common Stock On Open Market
MISSISSAUGA, Ontario , March 20, 2017 /PRNewswire/ --  Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) (Aralez or the Company) today announced that Adrian Adams , the Chief Executive Officer of the Company, acquired an additional 500,000 shares of the Company's common stock on March 15, 2017
Toggle Summary Aralez Reports Fourth Quarter And Full-Year 2016 Financial Results
-4Q16 Net Revenues Increased to $20 Million Versus $6 Million in the Comparable Period of 2015- -Full-Year Net Revenues Increased to $54.3 Million Versus $21.4 Million in the Comparable Period of 2015- -Provides 2017 Full-Year Guidance- MISSISSAUGA, Ontario , March 13, 2017 /PRNewswire/ --  Aralez
Toggle Summary Aralez To Announce Fourth Quarter And Full-Year 2016 Results On March 13, 2017
-Executive Management to Host Conference Call on March 13, 2017 at 9:00 a.m. ET - MISSISSAUGA, Ontario , Feb. 27, 2017 /PRNewswire/ --   Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) today announced that it will report its 2016 fourth quarter and full-year financial results on Monday,
Toggle Summary Aralez to Present at the RBC Capital Markets Global Healthcare Conference
MISSISSAUGA, Ontario , Feb. 16, 2017 /PRNewswire/ --  Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), a global specialty pharmaceutical company, today announced that executive management will participate in the RBC Capital Markets Global Healthcare Conference to be held February 22-23, 2017
Toggle Summary Aralez To Ring Closing Bell At Nasdaq On February 14, 2017
MISSISSAUGA, Ontario , Feb. 13, 2017 /PRNewswire/ --  Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ) (TSX: ARZ), a global specialty pharmaceutical company, today announced the Company will ring the Nasdaq Closing Bell at the Nasdaq MarketSite in Times Square , New York at 4:00 p.m.
Toggle Summary Aralez Pharmaceuticals unveils new office in Ireland

Copyright West LLC. Minimum 15 minutes delayed.